191 related articles for article (PubMed ID: 33055462)
1. Safety and Efficacy of Simultaneous Inoculations of Pneumococcal and Influenza Vaccines in Patients with Coronary Artery Disease.
Shimada K; Morinaga H; Kiyanagi T; Miyazaki T; Nishitani-Yokoyama M; Okai I; Tamura H; Konishi H; Kurata T; Miyauchi K; Daida H
J Atheroscler Thromb; 2021 Aug; 28(8):826-834. PubMed ID: 33055462
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of simultaneous versus sequential administration of a 23-valent pneumococcal polysaccharide vaccine and a quadrivalent influenza vaccine in older individuals: A randomized, open-label, non-inferiority trial.
Nakashima K; Aoshima M; Ohfuji S; Yamawaki S; Nemoto M; Hasegawa S; Noma S; Misawa M; Hosokawa N; Yaegashi M; Otsuka Y
Hum Vaccin Immunother; 2018; 14(8):1923-1930. PubMed ID: 29561248
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and safety of concomitant MF59-adjuvanted influenza vaccine and 23-valent pneumococcal polysaccharide vaccine administration in older adults.
Song JY; Cheong HJ; Tsai TF; Chang HA; Choi MJ; Jeon JH; Kang SH; Jeong EJ; Noh JY; Kim WJ
Vaccine; 2015 Aug; 33(36):4647-52. PubMed ID: 25980426
[TBL] [Abstract][Full Text] [Related]
4. Prevention of mortality and pneumonia among nursing home older adults by dual pneumococcal and seasonal influenza vaccination during a pandemic caused by novel pandemic influenza A (H1N1).
Chan TC; Hung IF; Luk JK; Shea YF; Chan FH; Woo PC; Chu LW
J Am Med Dir Assoc; 2012 Oct; 13(8):698-703. PubMed ID: 22722051
[TBL] [Abstract][Full Text] [Related]
5. Coadministration of 13-valent pneumococcal conjugate and quadrivalent inactivated influenza vaccines in adults previously immunized with polysaccharide pneumococcal vaccine 23: a randomized clinical trial.
Thompson AR; Klein NP; Downey HJ; Patterson S; Sundaraiyer V; Watson W; Clarke K; Jansen KU; Sebastian S; Gruber WC; Scott DA; Schmöele-Thoma B
Hum Vaccin Immunother; 2019; 15(2):444-451. PubMed ID: 30303436
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 years.
Schwarz TF; Flamaing J; Rümke HC; Penzes J; Juergens C; Wenz A; Jayawardene D; Giardina P; Emini EA; Gruber WC; Schmoele-Thoma B
Vaccine; 2011 Jul; 29(32):5195-202. PubMed ID: 21619909
[TBL] [Abstract][Full Text] [Related]
7. Risk of fever after pediatric trivalent inactivated influenza vaccine and 13-valent pneumococcal conjugate vaccine.
Stockwell MS; Broder K; LaRussa P; Lewis P; Fernandez N; Sharma D; Barrett A; Sosa J; Vellozzi C
JAMA Pediatr; 2014 Mar; 168(3):211-9. PubMed ID: 24395025
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of influenza and pneumococcal vaccines on chronic obstructive pulmonary disease exacerbations.
Li Y; Zhang P; An Z; Yue C; Wang Y; Liu Y; Yuan X; Ma Y; Li K; Yin Z; Wang L; Wang H
Respirology; 2022 Oct; 27(10):844-853. PubMed ID: 35705329
[TBL] [Abstract][Full Text] [Related]
9. Randomized, controlled trial of a 13-valent pneumococcal conjugate vaccine administered concomitantly with an influenza vaccine in healthy adults.
Frenck RW; Gurtman A; Rubino J; Smith W; van Cleeff M; Jayawardene D; Giardina PC; Emini EA; Gruber WC; Scott DA; Schmöle-Thoma B
Clin Vaccine Immunol; 2012 Aug; 19(8):1296-303. PubMed ID: 22739693
[TBL] [Abstract][Full Text] [Related]
10. Preventive effects of pneumococcal and influenza vaccines on community-acquired pneumonia in older individuals in Japan: a case-control study.
Suzuki K; Kondo K; Washio M; Nakashima K; Kan S; Imai S; Yoshimura K; Ota C; Ohfuji S; Fukushima W; Hirota Y
Hum Vaccin Immunother; 2019; 15(9):2171-2177. PubMed ID: 30785356
[TBL] [Abstract][Full Text] [Related]
11. Assessment of functional antibacterial opsonophagocytic antibodies elicited by 13-valent pneumococcal conjugate vaccine administered concomitantly with trivalent influenza vaccine in a randomized clinical trial in adults aged ≥65 years.
Schwarz TF; Schmoele-Thoma B
Vaccine; 2013 Jan; 31(2):291-4. PubMed ID: 23123107
[TBL] [Abstract][Full Text] [Related]
12. Pneumococcal conjugate vaccine triggers a better immune response than pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia A randomized study by the Swedish CLL group.
Svensson T; Kättström M; Hammarlund Y; Roth D; Andersson PO; Svensson M; Nilsson I; Rombo L; Cherif H; Kimby E
Vaccine; 2018 Jun; 36(25):3701-3707. PubMed ID: 29748028
[TBL] [Abstract][Full Text] [Related]
13. The response to vaccination against influenza A(H1N1) 2009, seasonal influenza and Streptococcus pneumoniae in adult outpatients with ongoing treatment for cancer with and without rituximab.
Berglund A; Willén L; Grödeberg L; Skattum L; Hagberg H; Pauksens K
Acta Oncol; 2014 Sep; 53(9):1212-20. PubMed ID: 24865118
[TBL] [Abstract][Full Text] [Related]
14. Enhanced protective responses to a serotype-independent pneumococcal vaccine when combined with an inactivated influenza vaccine.
Babb R; Chen A; Ogunniyi AD; Hirst TR; Kara EE; McColl SR; Alsharifi M; Paton JC
Clin Sci (Lond); 2017 Jan; 131(2):169-180. PubMed ID: 27885052
[TBL] [Abstract][Full Text] [Related]
15. Role of vaccines.
Vora A
J Assoc Physicians India; 2012 Jan; 60 Suppl():29-32. PubMed ID: 23155823
[No Abstract] [Full Text] [Related]
16. Immunogenicity and safety of an inactivated quadrivalent influenza vaccine co-administered with a 23-valent pneumococcal polysaccharide vaccine versus separate administration, in adults ≥50years of age: Results from a phase III, randomized, non-inferiority trial.
Ofori-Anyinam O; Leroux-Roels G; Drame M; Aerssens A; Maes C; Amanullah A; Schuind A; Li P; Jain VK; Innis BL
Vaccine; 2017 Nov; 35(46):6321-6328. PubMed ID: 28987445
[TBL] [Abstract][Full Text] [Related]
17. Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept.
Alten R; Bingham CO; Cohen SB; Curtis JR; Kelly S; Wong D; Genovese MC
BMC Musculoskelet Disord; 2016 May; 17():231. PubMed ID: 27229685
[TBL] [Abstract][Full Text] [Related]
18. Late onset of injection site reactions after vaccination with the 13-valent pneumococcal conjugate vaccine in adult study populations.
Juergens C; Trammel J; Shoji Y; Patterson S; Watson W; Webber C; Gruber WC; Scott DA; Schmoele-Thoma B
Hum Vaccin Immunother; 2018; 14(8):1948-1956. PubMed ID: 29543583
[TBL] [Abstract][Full Text] [Related]
19. [Simultaneous vaccination against influenza and invasive pneumococcal disease in chronic dialysis patients].
Trmal J; Havlícková M; Bícová R; Bitterová Z; Kelerová J
Epidemiol Mikrobiol Imunol; 2005 Aug; 54(3):123-8. PubMed ID: 16173523
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial to compare the safety and immunogenicity of CSL Limited's 2009 trivalent inactivated influenza vaccine to an established vaccine in United States children.
Brady RC; Hu W; Houchin VG; Eder FS; Jackson KC; Hartel GF; Sawlwin DC; Albano FR; Greenberg M
Vaccine; 2014 Dec; 32(52):7141-7. PubMed ID: 25454878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
